Molecule Structure

Scientific Name

Moexipril

Description of the Drug

Moexipril is an angiotensin converting enzyme inhibitor prodrug used to treat hypertension.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00691

Brand Name(s)

Not Available

Company Owner(s)

Apotex Inc, Teva Pharmaceuticals Usa Inc, Glenmark Generics Ltd, Ucb Inc, Chartwell Rx Sciences Llc, Glenmark Pharmaceuticals Ltd, Heritage Pharmaceuticals Inc Dba Avet Pharmaceuticals Inc

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Angiotensin-converting enzyme SINGLE PROTEIN INHIBITOR CHEMBL1808

Unichem Links

SureChEMBL SCHEMBL34030
PharmGKB PA164769059
Human Metabolome Database HMDB0014829
DrugBank DB00691
PubChem: Thomson Pharma 14933223 14884255
PubChem 91270 40466988
LINCS LSM-2751
Nikkaji J557.758F
BindingDB 50084673
EPA CompTox Dashboard DTXSID9023330
DrugCentral 1827
ChemicalBook CB9338696
Guide to Pharmacology 6571
rxnorm MOEXIPRIL UNIRETIC MOEXIPRIL HYDROCHLORIDE UNIVASC
KEGG Ligand C07704
ChEBI 6960
ZINC ZINC000003812306